Date published: 2025-9-9

021-6093-6350

SCBT Portrait Logo
Seach Input

TAJ-β 抑制因子

TAJ-β inhibitors represent a specialized class of chemical compounds designed to specifically inhibit the function of the TAJ-β protein, a molecule known to play a role in various cellular regulatory pathways. TAJ-β inhibitors operate by binding to the active sites or key functional domains of the TAJ-β protein, thus preventing its normal activity within the cell. These inhibitors are often developed to fit the precise structural features of the TAJ-β protein, ensuring that they can effectively block its interactions or catalytic actions. The inhibitors may target different regions of the protein, such as its binding pockets or allosteric sites, depending on their mode of action and the specific mechanism by which they interfere with the protein's function. The chemical design of TAJ-β inhibitors is crucial for achieving a high degree of specificity, ensuring they interact with TAJ-β while minimizing interaction with other proteins.

TAJ-β inhibitors are synthesized using advanced organic synthesis techniques that allow the precise assembly of molecules with defined structural features. These compounds often feature a combination of hydrophobic and hydrophilic regions that are designed to complement the three-dimensional shape of the TAJ-β protein. Some inhibitors may include functional groups capable of forming strong covalent or non-covalent bonds with the protein's active sites, thereby enhancing their inhibitory potency. The solubility, stability, and reactivity of these inhibitors are carefully considered during their design, as these properties influence how effectively the inhibitor can interact with TAJ-β under different conditions. The diversity in the structural composition of TAJ-β inhibitors allows for the fine-tuning of their binding affinities, making them a valuable class of compounds for studying the biochemical functions and regulatory mechanisms associated with the TAJ-β protein.

Items 1 to 10 of 11 total

展示:

产品名称CAS #产品编号数量价格应用排名

SB 202190

152121-30-7sc-202334
sc-202334A
sc-202334B
1 mg
5 mg
25 mg
$30.00
$125.00
$445.00
45
(1)

抑制 p38 MAPK,可能会影响 TAJ-β 可能参与的炎症反应途径。

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K 抑制剂可能会破坏对细胞存活和增殖非常重要的信号通路。

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

JNK 抑制剂可能会影响与 TAJ-β 活性有关的应激反应途径和细胞凋亡。

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

MEK抑制剂,可能会影响MAPK/ERK通路,这可能与TAJ-β的功能有关。

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

另一种 PI3K 抑制剂可能会进一步影响 TAJ-β 假设参与的信号通路。

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR 抑制剂可能会调节与 TAJ-β 相关的细胞生长和自噬过程。

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

RAF 激酶抑制剂可影响涉及 TAJ-β 的细胞生长和分化途径。

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$74.00
256
(6)

泛天冬酶抑制剂,可能会影响 TAJ-β 可能调控的细胞凋亡途径。

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

蛋白酶体抑制剂可能会影响与 TAJ-β 功能相关的蛋白质降解途径。

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

调节 NF-κB 和其他信号分子,可能影响炎症和细胞生长。